Article
Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile
2024-01-16
Abstract excerpt
Glioblastoma (GB) remains one of the most treatment refractory and fatal tumour in humans. GB contains a population of self-renewing stem cells, the brain tumour stem cells (BTSC) that are highly resistant to therapy and are at the origin of tumour relapse. Here, we report, for the first time, that mubritinib potently impairs stemness and growth of patient-derived BTSCs harboring different oncogenic mutations. Mec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8566804-be96-5dcb-b8a8-d7a467950053
- DOI
- 10.1101/2024.01.15.574967
